Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen vs Placebo in Breast Cancer After Adjuvant Chemotherapy
NCT00002542Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jul 1993
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Tamoxifen with Placebo (2 arms). Primary endpoints: Overall Survival at 5 years and Disease-Free Survival at 5 years. Started Jul 1993; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002542.